Trial Assessing Tolerability News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial Assessing Tolerability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial Assessing Tolerability Today - Breaking & Trending Today

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Published: January 25, 2024

MELBOURNE, Australia and NEW YORK, Jan. 24, 2024 -- Incannex Healthcare Inc. , , a pharmaceutical company developing novel medicinal cannabinoid pharmacotherapies and psychedelic medicine...

Source: marketscreener.com

Related Topics:

United StatesJoel LathamLaine YonkerMark BleackleyIncannex Healthcare IncEdison GroupWorld Health OrganisationGlobenewswire IncHydroxychloroquine SulphatePatient Reported OutcomesScientific OfficerMagnetic Resonance ImagingHealth OrganisationTrial Assessing TolerabilitySecurities Litigation Reform ActExecutive OfficerRelations Contact